S&P 500 All time high of $42.47 June 6th, 2014 PolyOne Corporation Page 9 2006 Q1 2014 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 13.8% 12 – 16% Global Specialty Engineered Materials 1.1% 11.6% 12 – 16% Designed Structures & Solutions -- 6.5% 8 – 10% Performance Products & Solutions 5.5% 7.7% 9 – 12% Distribution 2.6% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 64% 65 – 75% 3) ROIC* 5.0% 9.4% 15% 4) Adjusted EPS Growth N/A 42% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period PolyOne Corporation Page 10 Bridge to $2.50 Adjusted EPS by 2015 2015 EPS: $2.50 2013 EPS: $1.31 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental Share Buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid Single Digit Revenue CAGR PolyOne Corporation Page 11 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 43.0% 2006 2013 Specialty Vitality Index Target ≥ 35% PolyOne Corporation Page 12 Healthcare Consumer Packaging and Additive Technology Transportation Unique and Innovative Solutions https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG PolyOne Corporation Page 13 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 14 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of March 31, 2014 Debt Maturities & Pension Funding – 3/31/14 Net Debt / EBITDA* = 1.9x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 3/31/2014 PolyOne Corporation Page 15 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return $0.16 $0.20 $0.24 $0.32 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend Expanding our sales, marketing, and technical capabilities Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin Synergy opportunities Adjacent material solutions Repurchased 1.4 million shares in Q1 2014 Repurchased 6.4 million shares since April 2013  13.6 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends  Investing in operational and LSS initiatives (including synergy capture) Manufacturing alignment PolyOne Corporation Page 16 Formula for Success Innovation Market Beating Performance Excellence in Execution PolyOne Corporation Page 17 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?

S&P 500 All time high of $39.55 May 13th, 2014 Page 8 2006 Q1 2014 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 13.8% 12 – 16% Global Specialty Engineered Materials 1.1% 11.6% 12 – 16% Designed Structures & Solutions -- 6.5% 8 – 10% Performance Products & Solutions 5.5% 7.7% 9 – 12% Distribution 2.6% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 64% 65 – 75% 3) ROIC* 5.0% 9.4% 15% 4) Adjusted EPS Growth N/A 42% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 9 Bridge to $2.50 Adjusted EPS by 2015 2015 EPS: $2.50 2013 EPS: $1.31 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental share buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid single digit revenue CAGR Page 10 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years Page 11 $20 $53 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 43.0% 2006 2013 Healthcare Consumer Packaging and Additive Technology Transportation Page 12 Unique and Innovative Solutions https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of March 31, 2014 Debt Maturities & Pension Funding – 3/31/14 Net Debt / EBITDA* = 1.9x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 3/31/2014 Page 13 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return $0.16 $0.20 $0.24 $0.32 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend  Expanding our sales, marketing, and technical capabilities  Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin  Synergy opportunities  Adjacent material solutions  Repurchased 1.4 million shares in Q1 2014  Repurchased 6.4 million shares since April 2013  13.6 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends  Investing in operational and LSS initiatives (including synergy capture) Manufacturing alignment Page 14 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?

Belgium Branch 08/11/2021 Registered seat Route de Bastogne 19 09/08/2018 9638 Pommerloch Luxembourg Website www.polyone.com Declarative 09/08/2018 Legal Situation Status Start Date End Date Normal situation Active 09/08/2018 Legal form Start Date End Date Foreign entity 09/08/2018 VAT activities Vesaliusstraat 31 - 1000 Brussels E: ol.brussel@xerius.be T: 02 609 62 30 26/11/2021 4Extract from Page 2from Functions Last Name, first Name Registered entity Start Date End DateReason for termination Representative (branch) Roels Jean-Marie 31/08/2018 Last Name, first Name Registered entity Start Date End DateReason for terminationEntrepreneurial skills - Ambulant commerce - Fairground operator 31/08/2018Non SME dispensation (Exemption) Characteristic Phase Duration Start Date End DateReason for termination Employer National Social Security Office Characteristic/authorisation 01/11/2018undetermined Subject to VAT Characteristic/authorisation 31/08/2018undetermined Enterprise subject to registration Characteristic/authorisation 01/11/2018undetermined General assembly End Date Financial Year Start Date Exceptional Year Start Date End DateEnd Date Exceptional Year Financial Details Share capital (Capital Stock) Currency Duration of the entity 12,000.00 EUR June 31/12 09/08/2018 Use Bank account number Start Date End DateBank account number Bank Accounts BIC For all purposes 685 8477013 57 31/08/2018BE09685847701357BOFABE3X External Identifiers NSSO number 143954886 Trade register number 19 0097620 There is no data available for the following sections: Authorisations, Working partners :, Ex-officio striking off, Links between registered entities List of branches Branch - Center of operations Rue Melville Wilson 2 09/08/2018 België 26/11/2021 4Extract from Page 3from Establishment unit number 2.278.618.585 Trade name French Avient S.à r.l., Belgium Branch 08/11/2021 Rue Melville Wilson 2 31/08/2018 België Website www.polyone.com Declarative 31/08/2018 31/08/2018Start date establishment unit End date establishment unit Start date link between entities End date link between entities 31/08/2018 Activities Wholesale trade of industrial chemicals: aniline, printing ink, essential oils, industrial gases, chemical glues, dyes, synthetic resin, methanol, paraffin, etc. It is therefore necessary to refer to the Belgian legislation in force in order to determine their scope. 26/11/2021 2Extract from Page 1from EXTRACT OF THE ESTABLISHMENT UNIT DETAILS Crossroads Bank of Enterprises: 0314.595.348 Establishment unit number 2.278.618.585 Trade name French Avient S.à r.l., Belgium Branch 08/11/2021 Rue Melville Wilson 2 31/08/2018 Belgium Website www.polyone.com Declarative 31/08/2018 31/08/2018Start date establishment unit End date establishment unit Start date link between entities End date link between entities 31/08/2018 Registered entity Legal Situation Normal situation Vesaliusstraat 31 - 1000 Brussels E: ol.brussel@xerius.be T: 02 609 62 30 26/11/2021 2Extract from Page 2from Activities Wholesale trade of industrial chemicals: aniline, printing ink, essential oils, industrial gases, chemical glues, dyes, synthetic resin, methanol, paraffin, etc.

Medical textile manufacturer MEDICAL TEXTILE MANUFACTURER A A M I S T A N D A R D G O W N S • Water repellent properties for nonwoven fabric • Fast and long-lasting water repellency • Usable in nonwoven SMS spunbond layer • Enhanced liquid repellency in spunbond layer • Eliminated the need for secondary water repellent coatings • Provided long lasting hydrophobic performance • Achieved IPA repellency grade 6 Cesa Fiber Additives Hydrophobic Solutions KEY REQUIREMENTS WHY AVIENT?

SWIMMING POOL CLEANER OEM C L E A N E R C O N N E C T O R • Durable and will not rust • Dimensional stability • Easy to process • Delivered a corrosion-resistant, long glass fiber-reinforced material with excellent strength and modulus to replace steel • Offered low moisture absorption and good chemical resistance to maintain performance • Responded quickly and provided local technology support on mold design and injection process OnForce Long Glass Fiber Nylon Composite KEY REQUIREMENTS WHY AVIENT?

LOADING DOCK SHELTERS R E I N F O R C I N G S T A Y S Replacement for steel or composite stays to provide reliable seal from external environment: • Withstand repeated flex and twisting, pass rigorous proprietary flexural testing requirements • Maintain performance in extreme temperatures • Enabled repeated twisting and flexing without failure, up to 90˚ bends, due to exceptional mechanical properties • Customized finishing to meet specific shape and edge surface requirements • Improved supply reliability with product manufactured in Montrose, CO Gordon Composites™ Thermoset Composite Springs KEY REQUIREMENTS WHY AVIENT?

EXTERNAL FIXATOR DEVICE S T A B I L I Z I N G R O D S • Durable material that withstands everyday use • Light weight for easy customer handling • Precise stiffness to support load requirements and extend product lifetime • Maintained stiffness and straightness necessary for halo applications • Provided superior strength-to-weight ratio vs. metal • Appealed to aesthetics while maintaining high performance needs • Maximized user comfort via customized Avient Design services Glasforms™ Carbon Fiber Rods KEY REQUIREMENTS WHY AVIENT?

MEDICAL DEVICE MANUFACTURER D I S P O S A B L E M E D I C A L T R A Y • Excellent wear resistance that can sustain a minimum of 2,000 rotations • Withstand freezing temperature as low as -20°C • Can be sterilized by EtO • Delivered excellent wear resistance performance to fully meet customer’s request • Provided dimensional stability required for this medical application • Reduced friction to lower the noise during operation LubriOne™ Internally Lubricated Formulation KEY REQUIREMENTS WHY AVIENT?

Trilliant XR - CT and MRI Scanners MEDICAL DEVICE MANUFACTURER M R I A N D C T S C A N N E R S • Uniform shielding with no “hot spots” • X-ray shielding up to 140 KeV • Meet European Union’s Restriction of Hazardous Substances (RoHS) future compliance requirements • Provided a lead alternative solution that delivered improved geometric flexibility for more uniform radiation shielding • Lowered shielding component costs 30-50% by eliminating machining and assembly steps Trilliant™ XR Lead Replacement Thermoplastics KEY REQUIREMENTS WHY AVIENT?

CABLE MANUFACTURER A N T E N N A P O W E R C A B L E • Elongation at -40°C • High temperature bend test at 130°C • Low water absorption • Resistance to braided shielding • Fire performance to pass CPR class Dca • Provided best cold performance compared to competitor solutions • Enabled faster processing with increased line speed • Met material fire performance requirements and all other performance criteria ECCOH™ 5565 Formulation KEY REQUIREMENTS WHY AVIENT?